Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 370

1.

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study.

Carcel C, Neal B, Oparil S, Rogers K, Narkiewicz K, Wang JG, Schiffrin EL, Poulter N, Azizi M, Chalmers J.

J Hypertens. 2019 Aug 13. doi: 10.1097/HJH.0000000000002184. [Epub ahead of print]

PMID:
31415307
2.

Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.

Yang WY, Melgarejo JD, Thijs L, Zhang ZY, Boggia J, Wei FF, Hansen TW, Asayama K, Ohkubo T, Jeppesen J, Dolan E, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Filipovský J, Maestre GE, Li Y, Wang JG, Imai Y, Kawecka-Jaszcz K, Sandoya E, Narkiewicz K, O'Brien E, Verhamme P, Staessen JA; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators.

JAMA. 2019 Aug 6;322(5):409-420. doi: 10.1001/jama.2019.9811.

PMID:
31386134
3.

Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension.

Cheng YB, Thijs L, Zhang ZY, Kikuya M, Yang WY, Melgarejo JD, Boggia J, Wei FF, Hansen TW, Yu CG, Asayama K, Ohkubo T, Dolan E, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Filipovský J, Maestre GE, Imai Y, Kawecka-Jaszcz K, Sandoya E, Narkiewicz K, Li Y, O'Brien E, Wang JG, Staessen JA; IDACO Investigators.

Hypertension. 2019 Aug 5:HYPERTENSIONAHA11913512. doi: 10.1161/HYPERTENSIONAHA.119.13512. [Epub ahead of print]

PMID:
31378104
4.

The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Aug;28(4):215-216. doi: 10.1080/08037051.2019.1625523. Epub 2019 Jun 11. No abstract available.

PMID:
31184508
5.

10Kin1day: A Bottom-Up Neuroimaging Initiative.

van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC.

Front Neurol. 2019 May 9;10:425. doi: 10.3389/fneur.2019.00425. eCollection 2019.

6.

The phenomenon of HbA1c stability and the risk of hypoglycemia in long-standing type 1 diabetes.

Wolnik B, Orłowska-Kunikowska E, Błaszkowska M, Graff B, Wolf J, Czupryniak L, Narkiewicz K.

Diabetes Res Clin Pract. 2019 Jun;152:96-102. doi: 10.1016/j.diabres.2019.05.010. Epub 2019 May 18.

PMID:
31108139
7.

Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Jun;28(3):144-145. doi: 10.1080/08037051.2019.1614278. No abstract available.

PMID:
31076016
8.

Do we know more about hypertension in Poland after the May Measurement Month 2017?-Europe.

Małyszko J, Mastej M, Banach M, Tykarski A, Narkiewicz K, Hoffman P, Jankowski P, Nowicki MP, Tomasik T, Windak A, Olszanecka A, Motyl A, Nowak D, Skowron Ł, Tomaszewski M, Beaney T, Xia X, Nillson P, Poulter NR, Jóźwiak J.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100. doi: 10.1093/eurheartj/suz067. Epub 2019 Apr 24.

9.

Telomere Length and Risk of Major Adverse Cardiac Events and Cancer in Obstructive Sleep Apnea Patients.

Polonis K, Sompalli S, Becari C, Xie J, Covassin N, Schulte PJ, Druliner BR, Johnson RA, Narkiewicz K, Boardman LA, Singh P, Somers VK.

Cells. 2019 Apr 26;8(5). pii: E381. doi: 10.3390/cells8050381.

10.

Impact of slow breathing on the blood pressure and subarachnoid space width oscillations in humans.

Nuckowska MK, Gruszecki M, Kot J, Wolf J, Guminski W, Frydrychowski AF, Wtorek J, Narkiewicz K, Winklewski PJ.

Sci Rep. 2019 Apr 17;9(1):6232. doi: 10.1038/s41598-019-42552-9.

11.

Take a Blood Pressure Pill or Benefit from Renal Denervation?

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Eur Heart J. 2018 Sep 1;39(33):3010-3012. doi: 10.1093/eurheartj/ehy440. No abstract available.

PMID:
30990870
12.

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.

Mahfoud F, Böhm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, Schlaich M, Williams B, Fahy M, Mancia G.

Eur Heart J. 2019 Mar 21. pii: ehz118. doi: 10.1093/eurheartj/ehz118. [Epub ahead of print]

PMID:
30907413
13.

Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update.

Borghi C, Narkiewicz K, Mancia G.

Cardiol J. 2019;26(1):99-101. doi: 10.5603/CJ.2019.0015. No abstract available.

14.

Aging and Hypertension - Independent or Intertwined White Matter Impairing Factors? Insights From the Quantitative Diffusion Tensor Imaging.

Sabisz A, Naumczyk P, Marcinkowska A, Graff B, Gąsecki D, Glińska A, Witkowska M, Jankowska A, Konarzewska A, Kwela J, Jodzio K, Szurowska E, Narkiewicz K.

Front Aging Neurosci. 2019 Feb 19;11:35. doi: 10.3389/fnagi.2019.00035. eCollection 2019.

15.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

Kardiol Pol. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. Polish. No abstract available.

16.

Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Apr;28(2):75-76. doi: 10.1080/08037051.2019.1584975. Epub 2019 Feb 26. No abstract available.

PMID:
30806086
17.

New data on antihypertensive drugs and risk of cancer: should we worry?

Burnier M, Narkiewicz K, Kjeldsen SE, Oparil S.

Blood Press. 2019 Feb;28(1):1-3. doi: 10.1080/08037051.2019.1568182. No abstract available.

PMID:
30714837
18.

Cognitive Dysfunction in Type 1 Diabetes Mellitus.

Shalimova A, Graff B, Gąsecki D, Wolf J, Sabisz A, Szurowska E, Jodzio K, Narkiewicz K.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2239-2249. doi: 10.1210/jc.2018-01315.

PMID:
30657922
19.

Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.

Szymański FM, Barylski M, Cybulska B, Wożakowska-Kapłon B, Krasiński Z, Mamcarz A, Widecka K, Płatek AE, Dudek D, Mickiewicz A, Kobayashi A, Dzida G, Grajek S, Wełnicki M, Zubilewicz T, Ufnal M, Hering D, Mizia-Stec K, Kasprzak J, Koziński M, Imiela J, Narkiewicz K, Gorczyca I, Postuła M, Jaguszewski MJ, Filipiak KJ.

Cardiol J. 2018;25(6):655-665. doi: 10.5603/CJ.2018.0141. Review. No abstract available.

20.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

G Ital Cardiol (Rome). 2018 Nov;19(11):3-73. doi: 10.1714/3026.30245. Italian. No abstract available.

PMID:
30520455

Supplemental Content

Loading ...
Support Center